Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Harvard Business School
Express Scripts
Moodys
Johnson and Johnson

Last Updated: May 24, 2022

Tg Theraps Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for TG THERAPS, and what generic alternatives to TG THERAPS drugs are available?

TG THERAPS has one approved drug.

There are eight US patents protecting TG THERAPS drugs.

There are fifty-eight patent family members on TG THERAPS drugs in thirty-one countries.

Summary for Tg Theraps
International Patents:58
US Patents:8
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Tg Theraps

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 RX Yes Yes 10,947,244 See Plans and Pricing See Plans and Pricing
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 RX Yes Yes 10,414,773 See Plans and Pricing Y Y See Plans and Pricing
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 RX Yes Yes 10,981,919 See Plans and Pricing See Plans and Pricing
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 RX Yes Yes 9,669,033 See Plans and Pricing See Plans and Pricing
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 RX Yes Yes 9,969,740 See Plans and Pricing Y Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Johnson and Johnson
McKinsey
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.